We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Boston Scientific Corporation | NYSE:BSX | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
-0.42 | -0.50% | 83.08 | 83.69 | 82.59 | 83.57 | 4,067,079 | 00:00:00 |
Delaware
|
|
1-11083
|
|
04-2695240
|
||
(State or other jurisdiction of incorporation or organization)
|
|
(Commission File Number)
|
|
(I.R.S. Employer Identification No.)
|
☐
|
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
|
Trading Symbol
|
|
Name of each exchange on which registered
|
Common Stock, $0.01 par value per share
|
|
BSX
|
|
New York Stock Exchange
|
0.625% Senior Notes due 2027
|
|
BSX27
|
|
New York Stock Exchange
|
ITEM 5.02.
|
DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.
|
(e)
|
Approval of Amendment and Restatement of Boston Scientific Corporation 2011 Long-Term Incentive Plan
|
ITEM 5.07.
|
SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.
|
(1)
|
All ten director nominees were elected to the Board for a one-year term to hold office until the Company’s 2021 Annual Meeting of Stockholders and until their successors have been elected and qualified.
|
Nominee
|
|
For
|
|
Withheld
|
|
Broker Non-Votes
|
Nelda J. Connors
|
|
1,057,992,312
|
|
122,676,483
|
|
39,284,677
|
Charles J. Dockendorff
|
|
1,161,565,990
|
|
19,102,805
|
|
39,284,677
|
Yoshiaki Fujimori
|
|
868,775,992
|
|
311,892,803
|
|
39,284,677
|
Donna A. James
|
|
1,173,526,756
|
|
7,142,039
|
|
39,284,677
|
Edward J. Ludwig
|
|
1,178,348,186
|
|
2,320,609
|
|
39,284,677
|
Stephen P. MacMillan
|
|
1,165,768,265
|
|
14,900,530
|
|
39,284,677
|
Michael F. Mahoney
|
|
1,127,019,830
|
|
53,648,965
|
|
39,284,677
|
David J. Roux
|
|
1,166,015,132
|
|
14,653,663
|
|
39,284,677
|
John E. Sununu
|
|
1,163,742,158
|
|
16,926,637
|
|
39,284,677
|
Ellen M. Zane
|
|
1,170,529,714
|
|
10,139,081
|
|
39,284,677
|
(2)
|
The advisory vote on the compensation for the Company’s “Named Executive Officers” as disclosed in the Company’s proxy statement for the Annual Meeting was approved.
|
For
|
|
Against
|
|
Abstain
|
|
Broker Non-Votes
|
1,112,264,746
|
|
64,868,413
|
|
3,535,636
|
|
39,284,677
|
(3)
|
The Amended 2011 Plan was approved.
|
For
|
|
Against
|
|
Abstain
|
|
Broker Non-Votes
|
1,143,647,557
|
|
36,191,927
|
|
829,311
|
|
39,284,677
|
(4)
|
The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the 2020 fiscal year was ratified.
|
For
|
|
Against
|
|
Abstain
|
1,175,919,370
|
|
43,496,695
|
|
537,407
|
(5)
|
The stockholder proposal requesting a report on inclusion of non-management employee representation on the Board of Directors was not approved.
|
For
|
|
Against
|
|
Abstain
|
|
Broker Non-Votes
|
46,305,831
|
|
1,132,479,087
|
|
1,883,877
|
|
39,284,677
|
ITEM 9.01.
|
FINANCIAL STATEMENTS AND EXHIBITS.
|
Exhibit No.
|
|
Description
|
10.1
|
|
|
104
|
|
Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document
|
Date:
|
May 12, 2020
|
BOSTON SCIENTIFIC CORPORATION
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Vance R. Brown
|
|
|
|
|
Vance R. Brown
|
|
|
|
|
Vice President and Chief Corporate Counsel
|
|
1 Year Boston Scientific Chart |
1 Month Boston Scientific Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions